Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%
Summary
Sunharbo (asundexian) is the first FDA-approved factor XIa inhibitor for secondary stroke prevention, but key limitations and risks do remain.
Description from Fox News.
Who is covering this
-
Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%
Sunharbo (asundexian) is the first FDA-approved factor XIa inhibitor for secondary stroke prevention, but key limitations and risks do remain.
Related stories
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
29 sourcesvia BBC NewsTruth score 9111
Actor Ajay Devgn moves High Court against FDA notice over Vimal Elaichi ads
7 sourcesvia The HinduTruth score 731
Blood pressure medication recalled nationwide
4 sourcesvia USA TODAYTruth score 671
Patanjali ghee among Rs 9 crore food stock seized in Maharashtra FDA crackdown
3 sourcesvia India TodayTruth score 54
Senate committee sets key vote for Trump FDA nominee
5 sourcesvia The HillTruth score 71
Urgent recall of coffee and vanilla ice cream sold at Lidl upgraded to highest risk level over contamination with listeria
3 sourcesvia Daily MailTruth score 53
Comments
Comments need JavaScript.